293 results
Page 2 of 15
8-K
EX-99.1
sfuol5x
13 Nov 23
CervoMed Reports Third Quarter 2023 Financial Results and Business Highlights
4:06pm
8-K
EX-99.1
miofw x0rt7mmv
25 Oct 23
Regulation FD Disclosure
5:18pm
8-K
EX-99.2
kpoyt7
25 Oct 23
Regulation FD Disclosure
5:18pm
8-K/A
EX-99.2
d30jcxfsqayc 9r
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
8-K/A
EX-99.3
cxw j6ma52a63n
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
8-K
EX-99.1
ve8zbr8bg0h2ad4ct
6 Sep 23
Other Events
4:05pm
8-K
EX-10.9
bicu8a7vvgmht1l183
17 Aug 23
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
4:15pm
8-K
b92jlf5 gtviv0y
17 Aug 23
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
4:15pm
8-K
EX-99.2
zdop20g5s 8awuw4
17 Aug 23
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
4:15pm
8-K
EX-99.1
8nsjqw3
17 Aug 23
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
4:15pm
425
EX-99.1
lramn1tifq6xg
14 Aug 23
Business combination disclosure
4:16pm
8-K
EX-99.1
7ol64 4y9c9
14 Aug 23
EIP Pharma Announces First Patient Dosed in RewinD-LB Phase 2b Clinical Trial Evaluating Neflamapimod in Dementia with Lewy Bodies
4:15pm
425
EX-99.2
2gu70wk
9 Aug 23
Business combination disclosure
4:02pm
8-K
EX-99.2
p4ukakgny4
9 Aug 23
Other Events
4:02pm
425
jq6slcfe0r4hxc9
3 Aug 23
Business combination disclosure
4:15pm
8-K
7572ajk8
3 Aug 23
Other Events
4:15pm
424B3
r6lz1
13 Jul 23
Prospectus supplement
4:32pm